Add to that MSB has been pulling in some ok % increase sales of TEMCELL in Japan and once GVHD is approved in the USA then I think in another 12 months time we can assume quarterly sales revenue of 4-8 million.
In other words enough to fund the company and start to save cash just from that product alone.
That doesn't supposed a 1billion dollar valuation though so hopefully other trials continue well. I'm just mentioning that if the other trials get good readouts then we are for sure a revenue positive company in another 12 months from today.
Coupled with good LVAD readout I think that definitely would indicate a 3-4billion valuation to be fair.
Add to that MSB has been pulling in some ok % increase sales of...
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
97.0¢ |
Change
-0.005(0.51%) |
Mkt cap ! $1.107B | |||
| Open | High | Low | Value | Volume |
| 98.5¢ | 98.5¢ | 96.0¢ | $2.168M | 2.226M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 16000 | 96.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 97.0¢ | 86854 | 7 |
View Market Depth
| Last trade - 16.10pm 23/08/2024 (20 minute delay) ? |
| MSB (ASX) Chart |